Literature DB >> 7573454

Impaired hepatocanalicular organic anion transport in endotoxemic rats.

H Roelofsen1, B Schoemaker, C Bakker, R Ottenhoff, P L Jansen, R P Elferink.   

Abstract

To investigate the mechanism of sepsis-associated hyperbilirubinemia we have studied hepatocanalicular transport of organic anions in a rat model of endotoxemia. Rats were injected intravenously with lipopolysaccharides (LPS), and at different times after injection, canalicular transport of 2,4-dinitrophenyl-S-glutathione (GS-DNP), as a model organic anion, was measured in perfused livers and isolated hepatocytes. In isolated liver perfusion experiments the initial biliary GS-DNP secretion rate was found to be significantly decreased 18 h after injection with 2 mg/kg LPS. In isolated hepatocytes from these rats, GS-DNP efflux rate was also significantly decreased (193.0 +/- 67 and 448.3 +/- 53 nmol.min-1.g dry wt-1 in endotoxemic and normal hepatocytes, respectively). Inhibition of GS-DNP effluxin isolated endotoxemic hepatocytes was dose dependent and reached a maximum with 0.25 mg/kg LPS. Inhibition was maximal at 12 h after LPS injection. Transport activity gradually returned to normal in 4-5 days after endotoxemia was induced. Dexamethasone pretreatment partially reversed the inhibition of GS-DNP transport in isolated endotoxemic hepatocytes. The phorbol ester phorbol 12-myristate 13-acetate increased GS-DNP efflux by 73 +/- 16 and 24 +/- 8% in endotoxemic and control hepatocytes, respectively, but could not restore the transport activity of endotoxemic hepatocytes to control levels. These results show that canalicular organic anion transport is decreased in the endotoxemic liver; this may play a role in the frequently observed hyperbilirubinemia during sepsis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573454     DOI: 10.1152/ajpgi.1995.269.3.G427

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Diagnostic approach to patients with cholestatic jaundice.

Authors:  N Assy; G Jacob; G Spira; Y Edoute
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.

Authors:  M Trauner; M Arrese; H Lee; J L Boyer; S J Karpen
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes.

Authors:  R Kubitz; U Warskulat; M Schmitt; D Häussinger
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

4.  Granulocyte colony-stimulating factor enhances endotoxin-induced decrease in biliary excretion of the antibiotic cefoperazone in rats.

Authors:  M Nadai; I Matsuda; L Wang; A Itoh; K Naruhashi; T Nabeshima; M Asai; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation.

Authors:  N Goda; K Suzuki; M Naito; S Takeoka; E Tsuchida; Y Ishimura; T Tamatani; M Suematsu
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

6.  Hepatobiliary excretion of cysteinyl leukotrienes in three experimental models of acute hepatic injury.

Authors:  H M Omar; R A Sanders; J B Watkins
Journal:  Inflamm Res       Date:  1996-10       Impact factor: 4.575

7.  Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats.

Authors:  H Ando; Y Nishio; K Ito; A Nakao; L Wang; Y L Zhao; K Kitaichi; K Takagi; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Hepatic expression of multidrug resistance protein 2 in biliary atresia.

Authors:  Keita Terui; Takeshi Saito; Tomoro Hishiki; Yoshiharu Sato; Tetsuya Mitsunaga; Hideo Yoshida
Journal:  Comp Hepatol       Date:  2011-08-03

9.  Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases.

Authors:  Eileen L Yoon; Hyung Joon Yim; Seung Young Kim; Jeong Han Kim; Ju-Han Lee; Young Sun Lee; Hyun Jung Lee; Sung Woo Jung; Sang Woo Lee; Jai Hyun Choi
Journal:  Korean J Hepatol       Date:  2010-09

Review 10.  Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.

Authors:  Jaap Mulder; Saul J Karpen; Uwe J F Tietge; Folkert Kuipers
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.